Centessa Pharmaceuticals is developing a portfolio of orexin receptor 2 (OX2R) agonists for the potential treatment of sleep-wake and other neuroscience disorders
Centessa Pharmaceuticals is developing a portfolio of orexin receptor 2 (OX2R) agonists for the potential treatment of sleep-wake and other neuroscience disorders.